These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 54484

  • 21. [The functional activity of plasminogen activators in the blood plasma and urine of patients with lupus nephritis].
    Poliantseva LR, Tareeva IE, Bobkova IN, Podorol'skaia LV, Andreenko GV.
    Ter Arkh; 1994; 66(6):39-41. PubMed ID: 7940365
    [Abstract] [Full Text] [Related]

  • 22. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
    Homma T, Ichikawa T.
    Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
    [Abstract] [Full Text] [Related]

  • 23. Plasma determination of plasminogen activator inhibitor 1 antigen must be performed in blood collected on antiplatelet/anticoagulant mixture.
    Juhan-Vague I, Alessi MC, Fossat C, Declerck PJ, Kruithof EK.
    Thromb Haemost; 1987 Dec 18; 58(4):1096. PubMed ID: 3127921
    [No Abstract] [Full Text] [Related]

  • 24. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.
    Paramo JA, de Boer A, Colucci M, Jonker JJ, Collen D.
    Thromb Haemost; 1985 Oct 30; 54(3):725. PubMed ID: 3937271
    [No Abstract] [Full Text] [Related]

  • 25. [Current developments in fibrinolytic therapy].
    Rijken DC.
    Ned Tijdschr Geneeskd; 1985 Sep 14; 129(37):1768-72. PubMed ID: 3934567
    [No Abstract] [Full Text] [Related]

  • 26. Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis.
    Mochan E, Uhl J.
    J Rheumatol; 1984 Apr 14; 11(2):123-8. PubMed ID: 6427461
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. On the reliability of plasminogen measurement employing the proactivator-activator converting method.
    Martin M.
    Thromb Haemost; 1976 Dec 31; 36(3):551-65. PubMed ID: 138961
    [Abstract] [Full Text] [Related]

  • 30. Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation.
    Virji MA, Aggarwal S, Kang Y.
    Transplant Proc; 1989 Jun 31; 21(3):3540-1. PubMed ID: 2500760
    [No Abstract] [Full Text] [Related]

  • 31. [The levels of antigens to plasminogen activators compared to their functional activity and inhibitor activity in patients with glomerulonephritis and amyloidosis].
    Bumblite ID, Poliantseva LR, Mukhin NA, Andreenko GV, Podorol'skaia LV, Liaginskiĭ AV, Varlamova NV.
    Ter Arkh; 1992 Jun 31; 64(11):52-6. PubMed ID: 1293845
    [No Abstract] [Full Text] [Related]

  • 32. [Identity of kininogenase and plasminogen activators in human granulocytes].
    Ogloblina OG, Platonova LV, Paskhina TS, Martynov VF, Sorochinskaia EI.
    Biokhimiia; 1984 Feb 31; 49(2):302-9. PubMed ID: 6424731
    [Abstract] [Full Text] [Related]

  • 33. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J, Rueda F.
    Sangre (Barc); 1985 Feb 31; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract] [Full Text] [Related]

  • 34. New assay for the plasminogen activator activity of transformed cells.
    Mangel WF, Livingston DC, Brocklehurst JR, Liu HY, Peltz GA, Cannon JF, Leytus SP, Wehrly JA, Salter BL, Mosher JL.
    Cold Spring Harb Symp Quant Biol; 1980 Feb 31; 44 Pt 1,():669-80. PubMed ID: 6448727
    [No Abstract] [Full Text] [Related]

  • 35. Influence of beta-sitosterol on the fibrinolytic potential in rabbits.
    Hoffmann A, Klöcking HP.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Feb 31; 115(1-2):189-96. PubMed ID: 2459019
    [Abstract] [Full Text] [Related]

  • 36. Mechanisms of inhibition of tissue-type plasminogen activator in blood.
    Collen D.
    Thromb Haemost; 1983 Oct 31; 50(3):678. PubMed ID: 6417816
    [No Abstract] [Full Text] [Related]

  • 37. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 31; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 38. [Molecular markers of hemostatic mechanisms--interaction of plasminogen activator and its inhibitor].
    Sakata Y.
    Rinsho Byori; 1989 Mar 31; 37(3):256-60. PubMed ID: 2787424
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.